The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Venous Thromboembolism Treatment Options Market Research Report 2024
Synopsis
The most common treatment for deep vein thrombosis is the use of anticoagulants, also known as blood thinners. These medicines, which can be taken by injection or pill, can reduce your blood's ability to clot. They don't break down existing clots, but they prevent them from getting bigger and reduce the risk of more clots forming. Injectable drugs can be given either subcutaneously or intravenously.
Due to the COVID-19 pandemic, the global Venous Thromboembolism Treatment Options market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Venous Thromboembolism Treatment Options market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Venous Thromboembolism Treatment Options landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Upper Pneumatic Compression Sleeves accounting for % of the Venous Thromboembolism Treatment Options global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Venous Thromboembolism Treatment Options include AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, Teleflex Inc., Boston Scientific Corp. and Janssen Pharmaceuticals, Inc, etc. In terms of revenue, the global 3 largest players have a % market share of Venous Thromboembolism Treatment Options in 2021.
This report focuses on Venous Thromboembolism Treatment Options volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Venous Thromboembolism Treatment Options market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Venous Thromboembolism Treatment Options Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Upper Pneumatic Compression Sleeves
Lower Pneumatic Compression Sleeves
Permanent Inferior Vena Cava Filters
Others
Segment by Application
Hospitals
Catheterisation Laboratories
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AngioDynamics
Cardinal Health Inc.
BTG International Ltd.
Stryker Corporation
DJO Global Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
Janssen Pharmaceuticals, Inc
The most common treatment for deep vein thrombosis is the use of anticoagulants, also known as blood thinners. These medicines, which can be taken by injection or pill, can reduce your blood's ability to clot. They don't break down existing clots, but they prevent them from getting bigger and reduce the risk of more clots forming. Injectable drugs can be given either subcutaneously or intravenously.
Due to the COVID-19 pandemic, the global Venous Thromboembolism Treatment Options market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Venous Thromboembolism Treatment Options market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Venous Thromboembolism Treatment Options landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Upper Pneumatic Compression Sleeves accounting for % of the Venous Thromboembolism Treatment Options global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Venous Thromboembolism Treatment Options include AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, Teleflex Inc., Boston Scientific Corp. and Janssen Pharmaceuticals, Inc, etc. In terms of revenue, the global 3 largest players have a % market share of Venous Thromboembolism Treatment Options in 2021.
This report focuses on Venous Thromboembolism Treatment Options volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Venous Thromboembolism Treatment Options market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Venous Thromboembolism Treatment Options Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Upper Pneumatic Compression Sleeves
Lower Pneumatic Compression Sleeves
Permanent Inferior Vena Cava Filters
Others
Segment by Application
Hospitals
Catheterisation Laboratories
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AngioDynamics
Cardinal Health Inc.
BTG International Ltd.
Stryker Corporation
DJO Global Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
Janssen Pharmaceuticals, Inc
Index1 Venous Thromboembolism Treatment Options Market Overview
1.1 Product Overview and Scope of Venous Thromboembolism Treatment Options
1.2 Venous Thromboembolism Treatment Options Segment by Type
1.2.1 Global Venous Thromboembolism Treatment Options Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Upper Pneumatic Compression Sleeves
1.2.3 Lower Pneumatic Compression Sleeves
1.2.4 Permanent Inferior Vena Cava Filters
1.2.5 Others
1.3 Venous Thromboembolism Treatment Options Segment by Application
1.3.1 Global Venous Thromboembolism Treatment Options Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Catheterisation Laboratories
1.3.4 Ambulatory Surgical Centers
1.4 Global Venous Thromboembolism Treatment Options Market Size Estimates and Forecasts
1.4.1 Global Venous Thromboembolism Treatment Options Revenue 2017-2028
1.4.2 Global Venous Thromboembolism Treatment Options Sales 2017-2028
1.4.3 Venous Thromboembolism Treatment Options Market Size by Region: 2017 Versus 2021 Versus 2028
2 Venous Thromboembolism Treatment Options Market Competition by Manufacturers
2.1 Global Venous Thromboembolism Treatment Options Sales Market Share by Manufacturers (2017-2022)
2.2 Global Venous Thromboembolism Treatment Options Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Venous Thromboembolism Treatment Options Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Venous Thromboembolism Treatment Options Manufacturing Sites, Area Served, Product Type
2.5 Venous Thromboembolism Treatment Options Market Competitive Situation and Trends
2.5.1 Venous Thromboembolism Treatment Options Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Venous Thromboembolism Treatment Options Players Market Share by Revenue
2.5.3 Global Venous Thromboembolism Treatment Options Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Venous Thromboembolism Treatment Options Retrospective Market Scenario by Region
3.1 Global Venous Thromboembolism Treatment Options Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Venous Thromboembolism Treatment Options Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Venous Thromboembolism Treatment Options Market Facts & Figures by Country
3.3.1 North America Venous Thromboembolism Treatment Options Sales by Country
3.3.2 North America Venous Thromboembolism Treatment Options Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Venous Thromboembolism Treatment Options Market Facts & Figures by Country
3.4.1 Europe Venous Thromboembolism Treatment Options Sales by Country
3.4.2 Europe Venous Thromboembolism Treatment Options Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Venous Thromboembolism Treatment Options Market Facts & Figures by Region
3.5.1 Asia Pacific Venous Thromboembolism Treatment Options Sales by Region
3.5.2 Asia Pacific Venous Thromboembolism Treatment Options Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Venous Thromboembolism Treatment Options Market Facts & Figures by Country
3.6.1 Latin America Venous Thromboembolism Treatment Options Sales by Country
3.6.2 Latin America Venous Thromboembolism Treatment Options Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Venous Thromboembolism Treatment Options Market Facts & Figures by Country
3.7.1 Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country
3.7.2 Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Venous Thromboembolism Treatment Options Historic Market Analysis by Type
4.1 Global Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2022)
4.2 Global Venous Thromboembolism Treatment Options Revenue Market Share by Type (2017-2022)
4.3 Global Venous Thromboembolism Treatment Options Price by Type (2017-2022)
5 Global Venous Thromboembolism Treatment Options Historic Market Analysis by Application
5.1 Global Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2022)
5.2 Global Venous Thromboembolism Treatment Options Revenue Market Share by Application (2017-2022)
5.3 Global Venous Thromboembolism Treatment Options Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AngioDynamics
6.1.1 AngioDynamics Corporation Information
6.1.2 AngioDynamics Description and Business Overview
6.1.3 AngioDynamics Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AngioDynamics Venous Thromboembolism Treatment Options Product Portfolio
6.1.5 AngioDynamics Recent Developments/Updates
6.2 Cardinal Health Inc.
6.2.1 Cardinal Health Inc. Corporation Information
6.2.2 Cardinal Health Inc. Description and Business Overview
6.2.3 Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Cardinal Health Inc. Venous Thromboembolism Treatment Options Product Portfolio
6.2.5 Cardinal Health Inc. Recent Developments/Updates
6.3 BTG International Ltd.
6.3.1 BTG International Ltd. Corporation Information
6.3.2 BTG International Ltd. Description and Business Overview
6.3.3 BTG International Ltd. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2017-2022)
6.3.4 BTG International Ltd. Venous Thromboembolism Treatment Options Product Portfolio
6.3.5 BTG International Ltd. Recent Developments/Updates
6.4 Stryker Corporation
6.4.1 Stryker Corporation Corporation Information
6.4.2 Stryker Corporation Description and Business Overview
6.4.3 Stryker Corporation Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Stryker Corporation Venous Thromboembolism Treatment Options Product Portfolio
6.4.5 Stryker Corporation Recent Developments/Updates
6.5 DJO Global Inc.
6.5.1 DJO Global Inc. Corporation Information
6.5.2 DJO Global Inc. Description and Business Overview
6.5.3 DJO Global Inc. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2017-2022)
6.5.4 DJO Global Inc. Venous Thromboembolism Treatment Options Product Portfolio
6.5.5 DJO Global Inc. Recent Developments/Updates
6.6 EKOS Corp
6.6.1 EKOS Corp Corporation Information
6.6.2 EKOS Corp Description and Business Overview
6.6.3 EKOS Corp Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2017-2022)
6.6.4 EKOS Corp Venous Thromboembolism Treatment Options Product Portfolio
6.6.5 EKOS Corp Recent Developments/Updates
6.7 Teleflex Inc., Boston Scientific Corp.
6.6.1 Teleflex Inc., Boston Scientific Corp. Corporation Information
6.6.2 Teleflex Inc., Boston Scientific Corp. Description and Business Overview
6.6.3 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product Portfolio
6.7.5 Teleflex Inc., Boston Scientific Corp. Recent Developments/Updates
6.8 Janssen Pharmaceuticals, Inc
6.8.1 Janssen Pharmaceuticals, Inc Corporation Information
6.8.2 Janssen Pharmaceuticals, Inc Description and Business Overview
6.8.3 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product Portfolio
6.8.5 Janssen Pharmaceuticals, Inc Recent Developments/Updates
7 Venous Thromboembolism Treatment Options Manufacturing Cost Analysis
7.1 Venous Thromboembolism Treatment Options Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Venous Thromboembolism Treatment Options
7.4 Venous Thromboembolism Treatment Options Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Venous Thromboembolism Treatment Options Distributors List
8.3 Venous Thromboembolism Treatment Options Customers
9 Venous Thromboembolism Treatment Options Market Dynamics
9.1 Venous Thromboembolism Treatment Options Industry Trends
9.2 Venous Thromboembolism Treatment Options Market Drivers
9.3 Venous Thromboembolism Treatment Options Market Challenges
9.4 Venous Thromboembolism Treatment Options Market Restraints
10 Global Market Forecast
10.1 Venous Thromboembolism Treatment Options Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Venous Thromboembolism Treatment Options by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Venous Thromboembolism Treatment Options by Type (2023-2028)
10.2 Venous Thromboembolism Treatment Options Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Venous Thromboembolism Treatment Options by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Venous Thromboembolism Treatment Options by Application (2023-2028)
10.3 Venous Thromboembolism Treatment Options Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Venous Thromboembolism Treatment Options by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Venous Thromboembolism Treatment Options by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Venous Thromboembolism Treatment Options Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Venous Thromboembolism Treatment Options Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Venous Thromboembolism Treatment Options Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Venous Thromboembolism Treatment Options Market Competitive Situation by Manufacturers in 2021
Table 5. Global Venous Thromboembolism Treatment Options Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Venous Thromboembolism Treatment Options Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Venous Thromboembolism Treatment Options Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Venous Thromboembolism Treatment Options Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Venous Thromboembolism Treatment Options Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Venous Thromboembolism Treatment Options Manufacturing Sites and Area Served
Table 11. Manufacturers Venous Thromboembolism Treatment Options Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Venous Thromboembolism Treatment Options by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Venous Thromboembolism Treatment Options as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Venous Thromboembolism Treatment Options Sales by Region (2017-2022) & (K Units)
Table 16. Global Venous Thromboembolism Treatment Options Sales Market Share by Region (2017-2022)
Table 17. Global Venous Thromboembolism Treatment Options Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Venous Thromboembolism Treatment Options Revenue Market Share by Region (2017-2022)
Table 19. North America Venous Thromboembolism Treatment Options Sales by Country (2017-2022) & (K Units)
Table 20. North America Venous Thromboembolism Treatment Options Sales Market Share by Country (2017-2022)
Table 21. North America Venous Thromboembolism Treatment Options Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Venous Thromboembolism Treatment Options Revenue Market Share by Country (2017-2022)
Table 23. Europe Venous Thromboembolism Treatment Options Sales by Country (2017-2022) & (K Units)
Table 24. Europe Venous Thromboembolism Treatment Options Sales Market Share by Country (2017-2022)
Table 25. Europe Venous Thromboembolism Treatment Options Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Venous Thromboembolism Treatment Options Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Venous Thromboembolism Treatment Options Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Venous Thromboembolism Treatment Options Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Venous Thromboembolism Treatment Options Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Venous Thromboembolism Treatment Options Revenue Market Share by Region (2017-2022)
Table 31. Latin America Venous Thromboembolism Treatment Options Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Venous Thromboembolism Treatment Options Sales Market Share by Country (2017-2022)
Table 33. Latin America Venous Thromboembolism Treatment Options Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Venous Thromboembolism Treatment Options Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Venous Thromboembolism Treatment Options Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Venous Thromboembolism Treatment Options Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Venous Thromboembolism Treatment Options Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Venous Thromboembolism Treatment Options Revenue Market Share by Country (2017-2022)
Table 39. Global Venous Thromboembolism Treatment Options Sales by Type (2017-2022) & (K Units)
Table 40. Global Venous Thromboembolism Treatment Options Sales Market Share by Type (2017-2022)
Table 41. Global Venous Thromboembolism Treatment Options Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Venous Thromboembolism Treatment Options Revenue Share by Type (2017-2022)
Table 43. Global Venous Thromboembolism Treatment Options Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Venous Thromboembolism Treatment Options Sales (K Units) by Application (2017-2022)
Table 45. Global Venous Thromboembolism Treatment Options Sales Market Share by Application (2017-2022)
Table 46. Global Venous Thromboembolism Treatment Options Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Venous Thromboembolism Treatment Options Revenue Share by Application (2017-2022)
Table 48. Global Venous Thromboembolism Treatment Options Price by Application (2017-2022) & (US$/Unit)
Table 49. AngioDynamics Corporation Information
Table 50. AngioDynamics Description and Business Overview
Table 51. AngioDynamics Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. AngioDynamics Venous Thromboembolism Treatment Options Product
Table 53. AngioDynamics Recent Developments/Updates
Table 54. Cardinal Health Inc. Corporation Information
Table 55. Cardinal Health Inc. Description and Business Overview
Table 56. Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Cardinal Health Inc. Venous Thromboembolism Treatment Options Product
Table 58. Cardinal Health Inc. Recent Developments/Updates
Table 59. BTG International Ltd. Corporation Information
Table 60. BTG International Ltd. Description and Business Overview
Table 61. BTG International Ltd. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. BTG International Ltd. Venous Thromboembolism Treatment Options Product
Table 63. BTG International Ltd. Recent Developments/Updates
Table 64. Stryker Corporation Corporation Information
Table 65. Stryker Corporation Description and Business Overview
Table 66. Stryker Corporation Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Stryker Corporation Venous Thromboembolism Treatment Options Product
Table 68. Stryker Corporation Recent Developments/Updates
Table 69. DJO Global Inc. Corporation Information
Table 70. DJO Global Inc. Description and Business Overview
Table 71. DJO Global Inc. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. DJO Global Inc. Venous Thromboembolism Treatment Options Product
Table 73. DJO Global Inc. Recent Developments/Updates
Table 74. EKOS Corp Corporation Information
Table 75. EKOS Corp Description and Business Overview
Table 76. EKOS Corp Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. EKOS Corp Venous Thromboembolism Treatment Options Product
Table 78. EKOS Corp Recent Developments/Updates
Table 79. Teleflex Inc., Boston Scientific Corp. Corporation Information
Table 80. Teleflex Inc., Boston Scientific Corp. Description and Business Overview
Table 81. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product
Table 83. Teleflex Inc., Boston Scientific Corp. Recent Developments/Updates
Table 84. Janssen Pharmaceuticals, Inc Corporation Information
Table 85. Janssen Pharmaceuticals, Inc Description and Business Overview
Table 86. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product
Table 88. Janssen Pharmaceuticals, Inc Recent Developments/Updates
Table 89. Production Base and Market Concentration Rate of Raw Material
Table 90. Key Suppliers of Raw Materials
Table 91. Venous Thromboembolism Treatment Options Distributors List
Table 92. Venous Thromboembolism Treatment Options Customers List
Table 93. Venous Thromboembolism Treatment Options Market Trends
Table 94. Venous Thromboembolism Treatment Options Market Drivers
Table 95. Venous Thromboembolism Treatment Options Market Challenges
Table 96. Venous Thromboembolism Treatment Options Market Restraints
Table 97. Global Venous Thromboembolism Treatment Options Sales Forecast by Type (2023-2028) & (K Units)
Table 98. Global Venous Thromboembolism Treatment Options Sales Market Share Forecast by Type (2023-2028)
Table 99. Global Venous Thromboembolism Treatment Options Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 100. Global Venous Thromboembolism Treatment Options Revenue Market Share Forecast by Type (2023-2028)
Table 101. Global Venous Thromboembolism Treatment Options Sales Forecast by Application (2023-2028) & (K Units)
Table 102. Global Venous Thromboembolism Treatment Options Sales Market Share Forecast by Application (2023-2028)
Table 103. Global Venous Thromboembolism Treatment Options Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 104. Global Venous Thromboembolism Treatment Options Revenue Market Share Forecast by Application (2023-2028)
Table 105. Global Venous Thromboembolism Treatment Options Sales Forecast by Region (2023-2028) & (K Units)
Table 106. Global Venous Thromboembolism Treatment Options Sales Market Share Forecast by Region (2023-2028)
Table 107. Global Venous Thromboembolism Treatment Options Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 108. Global Venous Thromboembolism Treatment Options Revenue Market Share Forecast by Region (2023-2028)
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Venous Thromboembolism Treatment Options
Figure 2. Global Venous Thromboembolism Treatment Options Market Share by Type in 2021 & 2028
Figure 3. Upper Pneumatic Compression Sleeves Product Picture
Figure 4. Lower Pneumatic Compression Sleeves Product Picture
Figure 5. Permanent Inferior Vena Cava Filters Product Picture
Figure 6. Others Product Picture
Figure 7. Global Venous Thromboembolism Treatment Options Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Catheterisation Laboratories
Figure 10. Ambulatory Surgical Centers
Figure 11. Global Venous Thromboembolism Treatment Options Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Venous Thromboembolism Treatment Options Market Size (2017-2028) & (US$ Million)
Figure 13. Global Venous Thromboembolism Treatment Options Sales (2017-2028) & (K Units)
Figure 14. Venous Thromboembolism Treatment Options Sales Share by Manufacturers in 2021
Figure 15. Global Venous Thromboembolism Treatment Options Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Venous Thromboembolism Treatment Options Players: Market Share by Revenue in 2021
Figure 17. Venous Thromboembolism Treatment Options Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Venous Thromboembolism Treatment Options Sales Market Share by Region (2017-2022)
Figure 19. Global Venous Thromboembolism Treatment Options Sales Market Share by Region in 2021
Figure 20. Global Venous Thromboembolism Treatment Options Revenue Market Share by Region (2017-2022)
Figure 21. Global Venous Thromboembolism Treatment Options Revenue Market Share by Region in 2021
Figure 22. United States Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Venous Thromboembolism Treatment Options Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Venous Thromboembolism Treatment Options by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Venous Thromboembolism Treatment Options
Figure 46. Manufacturing Process Analysis of Venous Thromboembolism Treatment Options
Figure 47. Venous Thromboembolism Treatment Options Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
